Literature DB >> 4008339

Synthesis and antibacterial activity of 6315-S, a new member of the oxacephem antibiotic.

T Tsuji, H Satoh, M Narisada, Y Hamashima, T Yoshida.   

Abstract

The synthesis and in vitro activity of 7 beta-difluoromethylthioacetamido-7 alpha-methoxy-3-[[1-(hydroxyethyl)-1H- tetrazol-5-yl]thiomethyl]-1-oxa-3-cephem-4-carboxylic acid sodium salt, 6315-S, are described. 6315-S shows good antibacterial activity against Gram-positive and Gram-negative bacteria, being especially highly active against clinical isolates of Staphylococcus aureus resistant to either ampicillin or methicillin. The structure-activity relationship of related 1-oxa and 1-thia cephems is also presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008339     DOI: 10.7164/antibiotics.38.466

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  14 in total

1.  In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus.

Authors:  S Kobayashi; S Arai; S Hayashi; T Sakaguchi
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Increased susceptibility to cephamycin-type antibiotics of methicillin-resistant Staphylococcus aureus defective in penicillin-binding protein 2.

Authors:  K Murakami; K Nomura; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus.

Authors:  K Murakami; K Nomura; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  In vitro activity of flomoxef in comparison to other cephalosporins.

Authors:  C Simon; M Simon; C Plieth
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

5.  Pharmacokinetics and hemostasis following administration of a new, injectable oxacephem (6315-S, flomoxef) in volunteers and in patients with renal insufficiency.

Authors:  K Andrassy; J Koderisch; K Gorges; H Sonntag; K Hirauchi
Journal:  Infection       Date:  1991       Impact factor: 3.553

6.  In vitro activity of flomoxef and cefazolin in combination with vancomycin.

Authors:  C Simon; M Simon
Journal:  Infection       Date:  1991       Impact factor: 3.553

7.  Effect of flomoxef on blood coagulation and alcohol metabolism.

Authors:  K Uchida; T Matsubara
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 8.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

9.  In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Authors:  T Iwahi; K Okonogi; T Yamazaki; S Shiki; M Kondo; A Miyake; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.